QUEST DIAGNOSTICS

LeukoVantage panels utilize the latest in NGS technology, so you and your patients can know more, sooner, and make more informed treatment decisions... LeukoVantage is a panel that offers physicians testing solutions for these disease states: acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS) and other myeloid neoplasms. Based on a comprehensive literature review and updated guidelines for gene inclusion from the World Health Organization and National Comprehensive Cancer Network®, the analyzed genes can help physicians make a more informed diagnosis and more closely monitor disease progression and their patients' response to treatment... Make an early assessment of myelodysplastic syndrome (MDS)-detects mutated genes in early MDS when cytogenetics is uninformative 3

Also known as: Quest Diagnostics Incorporated